Clinical Trial

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

Study acronym: REPAIR
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This phase I/II escalation dose study is assessing the efficacy of the recommended dose of stereotactic re-irradiation (SBRT) of relapses within the prostatectomy bed, potentiated by metformin
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-08-27; most recent amendment 2026-06-18.
Status change: Recruiting → Active, Not Recruiting 2026-06-18
Status change: Not Yet Recruiting → Recruiting 2021-01-14
Trial Details
NCT Number NCT04536805
Lead Sponsor Institut Cancerologie de l'Ouest
Conditions Prostate Cancer
Enrollment 44 participants
Start Date 2020-11-17
Primary Completion 2031-11 (estimated)
Study Completion 2031-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-23